Introduction
============

The club cell secretory protein (CCSP or CC-10/uteroglobin) is produced by the nonciliary bronchial epithelium as well as the uterine and urethral ducts.[@b1-copd-11-2321] CCSP exhibits high homology with rabbit uteroglobin, which has multiple activities, including immunosuppressive, anti-inflammatory, antiproteinase, and antiphospholipase A2 activities.[@b2-copd-11-2321] This suggests that CCSP might play a role in the anti-inflammatory response.[@b3-copd-11-2321],[@b4-copd-11-2321] CCSP-deficient mice (CCSP−/−) have been reported to demonstrate more severe inflammation than wild-type controls in response to viral infection.[@b5-copd-11-2321] With regard to human diseases, correlations between smoking-related disease and serum or bronchoalveolar levels of CCSP have been well demonstrated.[@b1-copd-11-2321],[@b6-copd-11-2321] In addition, club cells have been found to be reduced in the lungs of asthmatics,[@b7-copd-11-2321] and CCSP concentrations were also reduced in the sera of asthmatics.[@b8-copd-11-2321] In large amounts, the protein can play an important role in lung homeostasis.

Although CCSP could play a role in the acute inflammatory response, reports concerning the relationship between CCSP and chronic lung disease have been quite limited. Recently, characterization of COPD has revealed that CCSP was strongly related to COPD progression.[@b9-copd-11-2321],[@b10-copd-11-2321] COPD is a major cause of chronic morbidity and mortality throughout the world. It is characterized by airflow limitation, which is not fully reversible. The disease results from an abnormal inflammatory response to inhaled particles and gases (mainly from smoking) in the lung.[@b11-copd-11-2321] COPD consists of pulmonary emphysema, destruction of alveoli, and chronic bronchitis -- diseases that mainly involve the bronchi. Recently, chronic *P. aeruginosa* infection has been reported to be associated with a greater severity of COPD.[@b12-copd-11-2321]

We hypothesized that CCSP could have a protective role against chronic inflammation-induced lung damage. Thus, CCSP deficiency would lead to more lung inflammation and result in the destruction of lung, the characteristic feature of COPD. To address this issue, we developed a mouse model of chronic *P. aeruginosa* infection using CCSP−/− mice, and the pathophysiology of the mouse model was determined.

Materials and methods
=====================

Animal model
------------

A bacterial culture of *P. aeruginosa* (PAO01 strain) was used to cause infection in this study. For animal model, CCSP-deficient mice (CCSP−/−) of the 129 strains background and 129 mice (wild-type) were used.[@b13-copd-11-2321] First, we made the chronic respiratory infection model of *P. aeruginosa* with modification of the method previously described.[@b14-copd-11-2321] An intravenous catheter of external diameter 1 mm was purchased from the Atom Medical Co. (Saitama, Japan). A tube of length 5 mm, which was soaked in fluid containing *P. aeruginosa* (PAO01 strain) at a concentration of 1×10^6^ CFU/mL for 1 week, was inserted into the trachea of the mice. One week later, *P. aeruginosa* (5×10^4^ CFU/animal) was administered intranasally; an untreated tube was inserted into the trachea of the control mice. Four weeks after intranasal administration of *P. aeruginosa*, the mice were sacrificed ([Figure 1A](#f1-copd-11-2321){ref-type="fig"}). Bacterial growth was examined in the bronchoalveolar lavage (BAL) fluids. The cell count in the BAL fluids was determined and the lung histology was also investigated. This study was approved by the Institutional Animal Care and Use Committee (IACUC) of Fukuoka University, and followed the Guidelines for Animal Experimentation, Fukuoka University (based on the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology). The IACUC is charged with protecting the safety and welfare of animals used in research at or in conjunction with Fukuoka University.

Lung histology and morphometry
------------------------------

The lungs were inflated at 25 cm H~2~O static pressure by intratracheal instillation of 4% paraformaldehyde in phosphate-buffered saline (PBS) prior to the staining of 4 µm thick tissue sections with hematoxylin and eosin (H&E), alcian blue staining, and Sirius red staining. The mean linear intercept (Lm), an indicator of air space size, was calculated for each mouse as described previously.[@b15-copd-11-2321]--[@b17-copd-11-2321] The destructive index (DI) was calculated to evaluate the destruction.[@b18-copd-11-2321] Stenosis was measured as the index of bronchial stenosis, which is equal to the area of the bronchial lumen divided by the area of the external bronchus. The area was measured using the Win Roof software program (version 5.5; Mitani Corporation, Tokyo, Japan).

BAL fluids
----------

In all the mice the lungs were lavaged with 0.5 mL aliquots of PBS ten times for a total of 5 mL. The total cell counts were determined with a hemocytometer. Differential counts of BAL fluid were performed on 200 cells from smears stained with a modified Wright's stain (DiffQuik; American Scientific Products, McGaw Park, IL, USA). BAL fluid supernatants were analyzed using an enzyme-linked immunosorbant assay (ELISA) kit according to the manufacturer's instructions (R&D Systems, Inc., Minneapolis, MN, USA). Inflammatory cytokines/chemokines such as interferon (IFN)-γ, keratinocyte-derived chemokine (KC), and tumor necrosis factor (TNF)-α were measured.

Pulmonary physiology
--------------------

A variety of pulmonary physiological parameters such as the pressure--volume curve (P--V) were examined according to previously described methods.[@b15-copd-11-2321]--[@b17-copd-11-2321],[@b19-copd-11-2321] From the P--V curve, static compliance was calculated using the slope of the early phase of the P--V curve.

Statistics
----------

The data were expressed as the mean ± standard error. The Mann--Whitney test was used to compare the two groups. A *P*-value of \<0.05 was considered to indicate a statistically significant difference. All the statistical analyses were performed using the JMP software program (version 7.0; SAS Institute Inc., Cary, NC, USA).

Results
=======

Chronic respiratory infection model
-----------------------------------

The numbers of *P. aeruginosa* colony forming units (CFU) in the BAL fluids at 1 and 4 weeks after intranasal administration were 11×10^4^ CFU/mL and 6×10^4^ CFU/mL, respectively. *P. aeruginosa* was continuously detected in BAL fluids during the 4 weeks ([Figure 1B](#f1-copd-11-2321){ref-type="fig"}). Inflammatory cell infiltrates were observed in the lung, mainly around the bronchus and small numbers were observed around the alveoli ([Figure 2A](#f2-copd-11-2321){ref-type="fig"}). Most of the mice in the experiment survived until sacrifice. These results indicated that a consistent chronic respiratory infection model of *P. aeruginosa* had been established.

CCSP−/− mice of the chronic infection model
-------------------------------------------

The macroscopic findings and histology of the naïve CCSP−/− mice were similar to the descriptions previously reported for naïve wild-type mice.[@b13-copd-11-2321] The lungs of the chronic infection mouse model were subjected to H&E staining. Inflammatory cell infiltration was observed around the alveoli and the bronchus. In comparison to wild-type mice, the bronchus of the CCSP−/− mice showed more severe inflammation and greater stenotic development in response to *P. aeruginosa* infection ([Figure 2A](#f2-copd-11-2321){ref-type="fig"}). The bronchi of *P. aeruginosa*-infected CCSP−/− mice were subjected to H&E, alcian blue, and Sirius red staining. Although bronchial stenosis and inflammation were apparent, neither mucus deposition nor fibrosis was observed in the bronchus ([Figure 2B](#f2-copd-11-2321){ref-type="fig"}).

The cell counts in the BAL fluids were also investigated. The number of neutrophils, but not the macrophages or lymphocytes, was significantly increased in the BAL fluids of the CCSP−/− mice in comparison to the wild-type mice ([Figure 3A](#f3-copd-11-2321){ref-type="fig"}). Cytokines in the BAL fluids were measured by the cytokine ELISA kit. The augmentation of the inflammatory cytokine, KC, was observed; however, it was not significant in IFN-γ and TNF-α ([Figure 3B](#f3-copd-11-2321){ref-type="fig"}).

Characterization of the animal model
------------------------------------

The histologic and physiologic findings of the naïve CCSP−/− mice were also similar to those of the naïve wild-type mice (data not shown). The index of bronchial stenosis was investigated. The bronchus of the CCSP−/− mice showed significantly greater stenotic development in comparison to wild-type mice ([Figure 4](#f4-copd-11-2321){ref-type="fig"}). The Lm was measured by previously reported methods to evaluate the emphysematous changes of the lung. The Lm in the CCSP−/− mice was significantly higher than in the wild-type mice ([Figure 5A](#f5-copd-11-2321){ref-type="fig"}). The DI was measured by previously reported methods to evaluate the destruction of the alveolus wall of the lung. The DI in the CCSP−/− mice was significantly higher than in the wild-type mice ([Figure 5B](#f5-copd-11-2321){ref-type="fig"}). P--V curves were drawn using the lung physiology data. The lung compliance was then calculated using the slope of the early phase of the P--V curve. The CCSP−/− mice showed significantly higher lung compliance than the wild-type mice ([Figure 5C](#f5-copd-11-2321){ref-type="fig"}).

Discussion
==========

In this study, we investigated the pathophysiological characterization in persistent *P. aeruginosa* infection in CCSP−/− mice. Chronic respiratory infection model of *P. aeruginosa* has been reported previously.[@b14-copd-11-2321] However, the procedure was too difficult to perform. The present procedure is simple and reproducible compared to the method reported previously. Insertion of the tube soaked in *P. aeruginosa*-containing fluids did not result in persistent infection. We found that the additional administration of *P. aeruginosa* at 7 days after insertion of the tube was a key factor for the establishment of chronic persistent infection.

Chronic inflammation of *P. aeruginosa* in CCSP−/− mice demonstrated the aggravated inflammation around the small bronchus and resulted in bronchial stenosis and emphysematous changes. This pathological condition is similar to that of chronic bronchitis and pulmonary emphysema, which are the characteristic findings of COPD. The relationship between CCSP and *P. aeruginosa* has been investigated previously.[@b20-copd-11-2321] However, the previous study used a model of acute *P. aeruginosa* infection. CCSP deficiency was associated with enhanced pulmonary inflammation and improved killing of bacteria after an acute pulmonary infection. Concentrations of the proinflammatory cytokines such as interleukin-1β and TNF-α were modestly increased after 6 and 24 hours, respectively, in CCSP−/− mice. CCSP plays a role in the modulation of pulmonary inflammation during infection and recovery. On the contrary, we used chronic *P. aeruginosa* inflammation model and clarified further the role of CCSP. Deletion of CCSP leads to chronic bronchitis and emphysematous change. The important role of CCSP in chronic inflammation was first identified in the present study.

Interestingly, we found that chronic *P. aeruginosa* inflammation produced chronic bronchitis and emphysematous change in the CCSP−/− mice. This model is therefore considered to be a chronic bronchitis-related emphysematous model. In humans, the pathology of COPD is characterized by small airway inflammation.[@b21-copd-11-2321] Recent studies have attempted to characterize COPD and demonstrated that CCSP is strongly related to COPD progression.[@b9-copd-11-2321],[@b10-copd-11-2321] In another study, chronic *P. aeruginosa* infection in COPD patients was reported to be associated with severe obstruction pattern.[@b12-copd-11-2321] In the present study, severe inflammation around small airways was remarkably observed. Chronic inflammation affects lung morphogenesis and causes several pathological involvements including COPD.[@b22-copd-11-2321] King described that chronic bronchitis resulted in bronchial stenosis and led to alveolar emphysema.[@b23-copd-11-2321] Moreover, CCSP has been demonstrated to be influenced by cytokines such as TNF-α, KC, or IFN-γ.[@b24-copd-11-2321],[@b25-copd-11-2321] These cytokines were found to be essential for the pathogenesis of COPD.[@b15-copd-11-2321]--[@b17-copd-11-2321],[@b26-copd-11-2321] Especially, KC levels increased after administration of elastase with increase of inflammation.[@b16-copd-11-2321] It is a plausible explanation that, in response to chronic inflammation by *P. aeruginosa*, the deletion of CCSP led to an increase in KC levels, resulted in severe inflammation around small airways, and finally caused destruction of lung architecture, findings which are similar to those observed in COPD patients. The limitation was that this model was chronic inflammation model induced by *P. aeruginosa*, but not human COPD model such as smoking. In future, we should investigate chronic smoking model using CCSP−/− mice.

CCSP widely distributes to the ducts, such as bronchioles and uterine or urinary ducts. We speculate that CCSP could play an important role in keeping ducts patent against chronic inflammation. Given the important role of CCSP, Gamez et al[@b27-copd-11-2321] have recently indicated that it might be a target for new treatments for bronchitis-related emphysema. The supplementation of CCSP will be achieved in future using this model. We should also seek to elucidate the role of CCSP in human disease.

Conclusion
==========

Chronic *P. aeruginosa* inflammation resulted in chronic bronchitis and emphysematous changes in the CCSP-deficient mice. CCSP could play an important role in protecting the host from the chronic inflammation-induced lung damage.
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![Schema of the animal model.\
**Notes:** (**A**) A tube of length 5 mm was soaked in the fluid containing *Pseudomonas aeruginosa* PAO01 strain at a concentration of 1×10^6^ colony forming units (CFU)/mL for 1 week. The tube was inserted into mice via tracheostomy. Seven days after tube insertion, 5×10^4^ CFU/animal of *P. aeruginosa* was administered into mice intranasally. Four weeks after intranasal administration, animals were sacrificed. (**B**) The numbers of *P. aeruginosa* CFU in the bronchoalveolar lavage (BAL) fluids at 1 and 4 weeks after intranasal administration of *P. aeruginosa* were 11×10^4^ CFU/mL and 6×10^4^ CFU/mL, respectively. *P. aeruginosa* was continuously detected in the BAL fluids over the course of 4 weeks. Each group consisted of three mice.\
**Abbreviation:** *P. aeruginosa*, *Pseudomonas aeruginosa*.](copd-11-2321Fig1){#f1-copd-11-2321}

![Lung histology of chronic *Pseudomonas aeruginosa* infection.\
**Notes:** (**A**) The macroscopic findings and histology, (a) wild-type (Wt) mice with *P. aerugionosa* infection, (b) club cell secretory protein deficiency (CCSP−/−) with *P. aerugionosa* infection, (c) naïve CCSP−/− mice. Inflammatory cell infiltrates were observed in the lung, mainly around the bronchus and slightly around the alveoli. The bronchus of the CCSP−/− mice (b) showed more severe inflammation and greater stenotic development than wild-type mice (a) in response to *P. aeruginosa* infection. Lung histology of naïve CCSP−/− mice showed similar findings to wild-type mice (c); hematoxylin and eosin (H&E) staining, original magnification: 100×. (**B**) The bronchus in CCSP−/− mice with *P. aeruginosa* infection was subjected to H&E staining (a), alcian blue staining (b), and Sirius red staining (c). Although bronchial stenosis and inflammation were apparent, neither mucus deposition nor fibrosis was observed in the bronchus (original magnification: 200×).](copd-11-2321Fig2){#f2-copd-11-2321}

![The BAL fluids of chronic *Pseudomonas aeruginosa* infection.\
**Notes:** (**A**) Cell counts in the BAL fluids, the neutrophils in the BAL fluids of the club cell secretory protein-deficient (CCSP−/−) mice were significantly increased in comparison to wild-type mice. Seven CCSP−/− mice and four wild-type mice were used. (**B**) The cytokine profile in BAL fluids, cytokines in the BAL fluids were measured by the cytokine ELISA kit. The augmentation of the inflammatory cytokine, KC, was observed in CCSP−/− mice. However, it was not significant in IFN-γ and TNF-α. Seven CCSP−/− mice and four wild-type mice were used.\
**Abbreviations:** BAL, bronchoalveolar lavage; Wt, wild-type; ns, no significant difference; ELISA, enzyme-linked immunosorbent assay; KC, keratinocyte-derived chemokine; IFN, interferon; TNF, tumor necrosis factor.](copd-11-2321Fig3){#f3-copd-11-2321}

![Stenosis of the bronchus after chronic *Pseudomonas aeruginosa* infection.\
**Notes:** (**A**) The index of bronchial stenosis was investigated by morphometry. The area of the external bronchus (a) and the bronchial lumen (b) was measured by a software program. (**B**) Then the index (area b/area a) was calculated. The bronchus of the club cell secretory protein-deficient (CCSP−/−) mice showed significantly greater stenotic development in comparison to wild-type mice. Four CCSP−/− mice and three wild-type mice were used.\
**Abbreviation:** Wt, wild-type.](copd-11-2321Fig4){#f4-copd-11-2321}

###### 

Lung morphometry in the mouse model of chronic *Pseudomonas aeruginosa* infection.

**Notes:** (**A**) The mean linear intercept (Lm) was measured by previously reported methods to evaluate the emphysematous changes of the lung. The Lm was significantly elevated in club cell secretory protein--deficient (CCSP−/−) mice in comparison with wild-type mice. Seven CCSP−/− mice and four wild-type mice were used. (**B**) The destructive index (DI) was measured by the previously reported methods to evaluate the destruction of the alveolus wall of the lung. The DI in the CCSP−/− mice was significantly elevated in comparison with wild-type mice. Seven CCSP−/− mice and four wild-type mice were used. (**C**) The lung compliance in the mouse model of chronic *P. aeruginosa* infection was measured. Pressure--volume (P--V) curves were drawn using the lung physiology data. Lung compliance was then calculated using the slope of the early phase of P--V curve. The lung compliance of CCSP−/− mice was significantly increased in comparison with wild-type mice. Eight CCSP−/− mice and four wild-type mice were used.

**Abbreviations:** Wt, wild-type; Cst, static lung compliance.
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